About
Cyclerion Therapeutics is a biopharmaceutical company developing personalized therapies for neuropsychiatric diseases, focusing primarily on treatment-resistant depression through a combination of therapeutics and biofeedback-driven personalized delivery systems.
Explore Cyclerion Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.